Corporate Finance



Vanguard Health Systems Inc.

Vanguard Health Systems Inc. announced earnings results for the fourth quarter and full year ended June 30, 2008.

PolyMedix, Inc.

PolyMedix, Inc. (OTCBB: PYMX) announced a private placement of 607,143 units at $7 per unit for gross proceeds of $4,250,000 on September 23, 2008. Each unit
 

Pluristem Therapeutics, Inc

Pluristem Therapeutics, Inc. has announced a Units, Common Stock, Warrants offering in the amount of $1.04 million.
 

Medtronic, Inc

Medtronic, Inc. has filed a Shelf Registration in the amount of $2589.00 million.
 

Bracco Diagnostics Inc. and Lantheus Medical Imaging, Inc

Biophan Technologies Inc.

 
Biophan Technologies Inc. announced execution of a prepayment agreement with the holders of its senior debt.

MIV Therapeutics Inc.

MIV Therapeutics Inc. reported continued excellent results of VESTAsync(TM), a polymer-free drug-eluting stent, at a twelve-month clinical follow up for all fifteen patients in its first-in-man (FIM) VESTASYNC I Trial.

Opexa Therapeutics, Inc

Opexa Therapeutics, Inc. has filed a Shelf Registration in the amount of $8.60 million.

Entrigue Surgical, Inc

Entrigue Surgical, Inc. announced that it has raised $6.4 million in its Series B round of funding led by existing investors Prism VentureWorks and The Vertical Group on September 18, 2008.
 

Wolters Kluwer NV

Wolters Kluwer NV announced that the company is in exclusive talks with the shareholders of UpToDate Inc with respect to the acquisition of UpToDate.
Syndicate content